The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
End-of-life care for newly diagnosed diffuse large B-cell lymphoma patients with poor survival outcomes.
 
Arun Muthiah
No Relationships to Disclose
 
Debolina Pramanik
No Relationships to Disclose
 
Taylor Brooks
No Relationships to Disclose
 
Allison Winter
No Relationships to Disclose
 
Robert Dean
No Relationships to Disclose
 
Craig Sauter
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; crispr therapeutics; Gilead Sciences; Ipsen; Kite, a Gilead company; MorphoSys; Ono Pharmaceutical; Syncopation Life Sciences
Research Funding - Affimed Therapeutics; CARGO; Nkarta; Sanofi
 
Brian Hill
Honoraria - Abbvie; AstraZeneca; Bayer; BeiGene; Celgene; Epizyme; Genentech; Gilead Sciences; Karyopharm Therapeutics; MorphoSys; Novartis; Novartis; Pfizer; Pharmacyclics
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Epizyme; Genentech; Gilead Sciences; Karyopharm Therapeutics; MorphoSys; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); Celgene (Inst); Genentech (Inst); Karyopharm Therapeutics (Inst); Kite/Gilead (Inst); Takeda (Inst); TG Therapeutics (Inst)
 
Deepa Jagadeesh
Consulting or Advisory Role - AFM; Daiichi Sankyo/Lilly; Genmab
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Debiopharm Group (Inst); Loxo/Lilly (Inst); MEI Pharma (Inst); MEI Pharma (Inst); Merck (Inst); Regeneron (Inst); Rhizen Pharmaceuticals (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
 
Paolo Caimi
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Autolus; Bristol Myers Squibb Foundation; Genentech; Genmab; Novartis
Research Funding - Abbvie; Genmab; Recordati